Vitamin D Supplementation Protects Against Bone Loss Following Inhalant Organic Dust and Lipopolysaccharide Exposures in Mice
-
2015/05/01
-
Details
-
Personal Author:Duryee MJ ; Dusad A ; Klassen LW ; Mikuls TR ; Poole JA ; Reynolds SJ ; Romberger DJ ; Staab EB ; Thiele GM ; Wang D ; West WW ; Wyatt TA
-
Description:Systemic bone loss is associated with airway inflammatory diseases; yet, strategies to halt disease progression from inhalant exposures are not clear. Vitamin D might be a potentially protective approach against noxious respirable environmental exposures. We sought to determine whether vitamin D supplementation represents a viable lung and bone protective strategy following repetitive inhalant treatments with organic dust extract (ODE) or lipopolysaccharide (LPS) in mice. C57BL/5 mice were maintained on diets with low (1 IU/D/g) or high (10 IU/D/g) vitamin D for 5 weeks, and treated with ODE from swine confinement facilities, LPS, or saline daily for 3 weeks per established intranasal inhalation protocol. Lungs, hind limbs, and sera were harvested for experimental outcomes. Serum 25-hydroxy vitamin D levels were 10-fold different between low/high vitamin D treatment groups with no differences between inhalant agents/saline treatments. Serum calcium levels were not affected. There was no difference in the magnitude of ODE- or LPS-induced inflammatory cell influx or lung histopathology between high/low vitamin D treatment groups. However, high vitamin D treatment reversed the loss of bone mineral density, bone volume, and bone microarchitecture deterioration induced by ODE or LPS as determined by micro-CT analysis. Bone-resorbing osteoclasts were also reduced by high vitamin D treatment. In the low vitamin D treatment groups, ODE induced the greatest degree of airway inflammatory consequences, and LPS induced the greatest degree of bone loss. Collectively, high concentration vitamin D was protective against systemic bone loss, but not airway inflammation, resulting from ODE- or LPS-induced airway injury. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0257-277X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:46-59
-
Volume:62
-
Issue:1
-
NIOSHTIC Number:nn:20052053
-
Citation:Immunol Res 2015 May; 62(1):46-59
-
Contact Point Address:Jill A. Poole, Pulmonary, Critical Care, Sleep & Allergy Division, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA
-
Email:japoole@unmc.edu
-
Federal Fiscal Year:2015
-
NORA Priority Area:
-
Performing Organization:Colorado State University - Ft. Collins
-
Peer Reviewed:True
-
Start Date:20030915
-
Source Full Name:Immunologic Research
-
End Date:20270914
-
Collection(s):
-
Main Document Checksum:urn:sha-512:324f578a0d890c6615f62906696fd950cc69c45012025fea33594e081c8727a4657d9bd9171c422a865833c08fb722312dc78002095810d6287812cbd2ff2712
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like